Short Interest in Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Declines By 70.0%

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) saw a significant decrease in short interest in September. As of September 15th, there was short interest totaling 300 shares, a decrease of 70.0% from the August 31st total of 1,000 shares. Based on an average trading volume of 41,900 shares, the short-interest ratio is presently 0.0 days. Based on an average trading volume of 41,900 shares, the short-interest ratio is presently 0.0 days.

Lixte Biotechnology Price Performance

Lixte Biotechnology stock opened at $0.18 on Friday. Lixte Biotechnology has a 52-week low of $0.02 and a 52-week high of $0.38. The firm has a fifty day moving average of $0.20 and a 200-day moving average of $0.11.

Lixte Biotechnology Company Profile

Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.